US5744515A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method and implantable article for promoting endothelialization
Assignee: University of Arizona
•
Filing: 1996-10-11
•
Granted: 1998-04-28
•
Expires: 2016-10-11
Abstract
Abstract A porous material with an appropriate surface chemistry that promotes capillary endothelialization is disclosed. The material has a porosity that is sufficient to allow capillary endothelialization and a tenaciously bound adhesion molecule that promotes the ingrowth of endothelial cells into the porosity of the material.
Inventors
- 👤 David L. Clapper
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 02:11
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/50; A61L27/56; A61L27/14; A61L27/16; A61L27/18; A61F; A61F2/00; A61F2/0077; A61F2/02; A61F2/04; A61F2/06; Y; Y10; Y10S; Y10S623/00; Y10S623/924
Claims Analysis
Total Claims: 48
Claim 1
Independent Claim
160 words
An article comprising an implantable medical device comprising a rigid, porous biomaterial selected from the group consisting of non-soluble synthetic polymers, metals and ceramics and providing a surface bearing immobilized adhesion molecules selected from the group consisting of fibronectin, laminin, collagen, and active peptide domains thereof, the adhesion molecules having been bound to each other or the surface of the biomaterial by the activation of one or more photoreactive groups covalently bound to the adhesion molecules, the photoreactive groups having been selected from the group consisting of photoreactive aryl ketones, azides, diazirines, ketenes and diazo compounds, the adhesion molecules being provided directly upon the surface in an amount suitable to promote capillary endothelialization of the device in vivo, wherein the adhesion molecule is capable of binding to the surface of a cell, and wherein the biomaterial is porous in that it provides channels or passages extending through the biomaterial and of sufficient dimensions to permit the growth of capillaries therethrough.
Claim 2
Dependent Claim
160 words
An article comprising an implantable medical device comprising a rigid, porous biomaterial selected from the group consisting of non-soluble synthetic polymers, metals and ceramics and providing a surface bearing immobilized adhesion molecules selected from the group consisting of fibronectin, laminin, collagen, and active peptide domains thereof, the adhesion molecules having been bound to each other or the surface of the biomaterial by the activation of one or more photoreactive groups covalently bound to the adhesion molecules, the photoreactive groups having been selected from the group consisting of photoreactive aryl ketones, azides, diazirines, ketenes and diazo compounds, the adhesion molecules being provided directly upon the surface in an amount suitable to promote capillary endothelialization of the device in vivo, wherein the adhesion molecule is capable of binding to the surface of a cell, and wherein the biomaterial is porous in that it provides channels or passages extending through the biomaterial and of sufficient dimensions to permit the growth of capillaries therethrough.
Claim 3
Dependent Claim
23 words
An article according to claim 1 wherein the biomaterial provides pores having an average diameter from about 5 microns to about 1 mm.
Claim 4
Dependent Claim
25 words
An article according to claim 2 wherein the biomaterial is selected from the group consisting of tetrafluoroethylene polymers, aromatic/aliphatic polyester resins, polyurethanes, and silicone rubbers.
Claim 5
Dependent Claim
36 words
An article according to claim 3 wherein the tetrafluoroethylene polymers comprise expanded polytetrafluoroethylene, the aromatic/aliphatic polyester resins comprise polyethylene terephthalate ("PET") or poly(butylene terephthalate) ("PBT"), and the silicone rubbers comprise heat cured rubbers or silicone elastomers.
Claim 6
Dependent Claim
12 words
An article according to claim 3 wherein the biomaterial is expanded polytetrafluoroethylene.
Claim 7
Dependent Claim
21 words
An article according to claim 5 wherein the expanded polytetrafluoroethylene exhibits on the order of 10 to 300 micron internodal distance.
Claim 8
Independent Claim
136 words
A method of preparing an implantable medical device comprising the steps of: (a) providing an implantable device comprising a rigid, porous biomaterial providing a surface, wherein the biomaterial is porous in that it provides channels or passages extending through the biomaterial and of sufficient dimensions to permit the growth of capillaries therethrough; (b) contacting the surface with adhesion molecules selected from the group consisting of fibronectin, laminin, collagen, and active peptide domains thereof, the adhesion molecules bearing one or more latent photoreactive groups selected from the group consisting of photoreactive aryl ketones, azides, diazirines, ketenes and diazo compounds; and (c) activating the photoreactive groups in order to immobilize the adhesion molecules by binding the adhesion molecules to each other or to the surface in an amount suitable to promote capillary endothelialization of the device in vivo.
Claim 9
Independent Claim
136 words
A method of preparing an implantable medical device comprising the steps of: (a) providing an implantable device comprising a rigid, porous biomaterial providing a surface, wherein the biomaterial is porous in that it provides channels or passages extending through the biomaterial and of sufficient dimensions to permit the growth of capillaries therethrough; (b) contacting the surface with adhesion molecules selected from the group consisting of fibronectin, laminin, collagen, and active peptide domains thereof, the adhesion molecules bearing one or more latent photoreactive groups selected from the group consisting of photoreactive aryl ketones, azides, diazirines, ketenes and diazo compounds; and (c) activating the photoreactive groups in order to immobilize the adhesion molecules by binding the adhesion molecules to each other or to the surface in an amount suitable to promote capillary endothelialization of the device in vivo.
Claim 10
Independent Claim
159 words
A method of using an implantable medical device comprising the steps of: (a) providing an implantable device comprising a rigid, porous biomaterial providing a surface, wherein the biomaterial is porous in that it provides channels or passages extending through the biomaterial and of sufficient dimensions to permit the growth of capillaries therethrough; (b) contacting the surface with adhesion molecules selected from the group consisting of fibronectin, laminin, collagen, and active peptide domains thereof, the adhesion molecules bearing one or more latent photoreactive groups selected from the group consisting of photoreactive aryl ketones, azides, diazirines, ketenes and diazo compounds; and (c) activating the photoreactive groups in order to immobilize the adhesion molecules by binding the adhesion molecules to each other or to the surface; and (d) implanting the device in contact with bodily tissues or fluids in order to promote capillary endothelialization of the device by the growth of capillary endothelial cells into the porosity of the biomaterial in vivo.
Claim 11
Independent Claim
159 words
A method of using an implantable medical device comprising the steps of: (a) providing an implantable device comprising a rigid, porous biomaterial providing a surface, wherein the biomaterial is porous in that it provides channels or passages extending through the biomaterial and of sufficient dimensions to permit the growth of capillaries therethrough; (b) contacting the surface with adhesion molecules selected from the group consisting of fibronectin, laminin, collagen, and active peptide domains thereof, the adhesion molecules bearing one or more latent photoreactive groups selected from the group consisting of photoreactive aryl ketones, azides, diazirines, ketenes and diazo compounds; and (c) activating the photoreactive groups in order to immobilize the adhesion molecules by binding the adhesion molecules to each other or to the surface; and (d) implanting the device in contact with bodily tissues or fluids in order to promote capillary endothelialization of the device by the growth of capillary endothelial cells into the porosity of the biomaterial in vivo.
Claim 12
Dependent Claim
136 words
An implantable medical device prepared by a process comprising the steps of: (a) providing an implantable device comprising a rigid, porous biomaterial providing a surface, wherein the biomaterial is porous in that it provides channels or passages extending through the biomaterial and of sufficient dimensions to permit the growth of capillaries therethrough; (b) contacting the surface with adhesion molecules selected from the group consisting of fibronectin, laminin, collagen, and active peptide domains thereof, the adhesion molecules bearing one or more latent photoreactive groups selected from the group consisting of photoreactive aryl ketones, azides, diazirines, ketenes and diazo compounds; and (c) activating the photoreactive groups in order to immobilize the adhesion molecules by binding the adhesion molecules to each other or to the surface in an amount suitable to promote capillary endothelialization of the device in vivo.
Claim 13
Dependent Claim
136 words
An implantable medical device prepared by a process comprising the steps of: (a) providing an implantable device comprising a rigid, porous biomaterial providing a surface, wherein the biomaterial is porous in that it provides channels or passages extending through the biomaterial and of sufficient dimensions to permit the growth of capillaries therethrough; (b) contacting the surface with adhesion molecules selected from the group consisting of fibronectin, laminin, collagen, and active peptide domains thereof, the adhesion molecules bearing one or more latent photoreactive groups selected from the group consisting of photoreactive aryl ketones, azides, diazirines, ketenes and diazo compounds; and (c) activating the photoreactive groups in order to immobilize the adhesion molecules by binding the adhesion molecules to each other or to the surface in an amount suitable to promote capillary endothelialization of the device in vivo.
Claim 14
Dependent Claim
17 words
An article according to claim 2 wherein the adhesion molecule comprises fibronectin and active peptide domains thereof.
Claim 15
Dependent Claim
17 words
An article according to claim 2 wherein the adhesion molecule comprises laminin and active peptide domains thereof.
Claim 16
Dependent Claim
17 words
An article according to claim 2 wherein the adhesion molecule comprises collagen and active peptide domains thereof.
Claim 17
Dependent Claim
22 words
An article according to claim 2 wherein the photoreactive groups comprise aryl ketones selected from the group consisting of acetophenone and benzophenone.
Claim 18
Dependent Claim
17 words
An article according to claim 3 wherein the article is in the form of a vascular graft.
Claim 19
Dependent Claim
23 words
A method according to claim 7 wherein the biomaterial provides pores having an average diameter from about 5 microns to about 1 mm.
Claim 20
Dependent Claim
25 words
A method according to claim 15 wherein the biomaterial is selected from the group consisting of tetrafluoroethylene polymers, aromatic/aliphatic polyester resins, polyurethanes, and silicone rubbers.
Claim 21
Dependent Claim
36 words
A method according to claim 16 wherein the tetrafluoroethylene polymers comprise expanded polytetrafluoroethylene, the aromatic/aliphatic polyester resins comprise polyethylene terephthalate ("PET") or poly(butylene terephthalate) ("PBT"), and the silicone rubbers comprise heat cured rubbers or silicone elastomers.
Claim 22
Dependent Claim
12 words
A method according to claim 17 wherein the biomaterial is expanded polytetrafluoroethylene.
Claim 23
Dependent Claim
21 words
A method according to claim 18 wherein the expanded polytetrafluoroethylene exhibits on the order of 10 to 300 micron internodal distance.
Claim 24
Dependent Claim
17 words
A method according to claim 15 wherein the adhesion molecule comprises fibronectin and active peptide domains thereof.
Claim 25
Dependent Claim
17 words
A method according to claim 15 wherein the adhesion molecule comprises laminin and active peptide domains thereof.
Claim 26
Dependent Claim
17 words
A method according to claim 15 wherein the adhesion molecule comprises collagen and active peptide domains thereof.
Claim 27
Dependent Claim
22 words
A method according to claim 15 wherein the photoreactive groups comprise aryl ketones selected from the group consisting of acetophenone and benzophenone.
Claim 28
Dependent Claim
17 words
A method according to claim 16 wherein the article is in the form of a vascular graft.
Claim 29
Dependent Claim
23 words
A method according to claim 8 wherein the biomaterial provides pores having an average diameter from about 5 microns to about 1 mm.
Claim 30
Dependent Claim
25 words
A method according to claim 25 wherein the biomaterial is selected from the group consisting of tetrafluoroethylene polymers, aromatic/aliphatic polyester resins, polyurethanes, and silicone rubbers.
Claim 31
Dependent Claim
36 words
A method according to claim 26 wherein the tetrafluoroethylene polymers comprise expanded polytetrafluoroethylene, the aromatic/aliphatic polyester resins comprise polyethylene terephthalate ("PET") or poly(butylene terephthalate) ("PBT"), and the silicone rubbers comprise heat cured rubbers or silicone elastomers.
Claim 32
Dependent Claim
12 words
A method according to claim 27 wherein the biomaterial is expanded polytetrafluoroethylene.
Claim 33
Dependent Claim
21 words
An article according to claim 28 wherein the expanded polytetrafluoroethylene exhibits on the order of 10 to 300 micron internodal distance.
Claim 34
Dependent Claim
17 words
A method according to claim 25 wherein the adhesion molecule comprises fibronectin and active peptide domains thereof.
Claim 35
Dependent Claim
17 words
A method according to claim 25 wherein the adhesion molecule comprises laminin and active peptide domains thereof.
Claim 36
Dependent Claim
17 words
A method according to claim 25 wherein the adhesion molecule comprises collagen and active peptide domains thereof.
Claim 37
Dependent Claim
22 words
A method according to claim 25 wherein the photoreactive groups comprise aryl ketones selected from the group consisting of acetophenone and benzophenone.
Claim 38
Dependent Claim
17 words
A method according to claim 26 wherein the article is in the form of a vascular graft.
Claim 39
Dependent Claim
23 words
A device according to claim 9 wherein the biomaterial provides pores having an average diameter from about 5 microns to about 1 mm.
Claim 40
Dependent Claim
25 words
A device according to claim 35 wherein the biomaterial is selected from the group consisting of tetrafluoroethylene polymers, aromatic/aliphatic polyester resins, polyurethanes, and silicone rubbers.
Claim 41
Dependent Claim
36 words
A device according to claim 36 wherein the tetrafluoroethylene polymers comprise expanded polytetrafluoroethylene, the aromatic/aliphatic polyester resins comprise polyethylene terephthalate ("PET") or poly(butylene terephthalate) ("PBT"), and the silicone rubbers comprise heat cured rubbers or silicone elastomers.
Claim 42
Dependent Claim
12 words
A device according to claim 37 wherein the biomaterial is expanded polytetrafluoroethylene.
Claim 43
Dependent Claim
21 words
A device according to claim 38 wherein the expanded polytetrafluoroethylene exhibits on the order of 10 to 300 micron internodal distance.
Claim 44
Dependent Claim
17 words
A device according to claim 35 wherein the adhesion molecule comprises fibronectin and active peptide domains thereof.
Claim 45
Dependent Claim
17 words
A device according to claim 35 wherein the adhesion molecule comprises laminin and active peptide domains thereof.
Claim 46
Dependent Claim
17 words
A device according to claim 35 wherein the adhesion molecule comprises collagen and active peptide domains thereof.
Claim 47
Dependent Claim
22 words
A device according to claim 35 wherein the photoreactive groups comprise aryl ketones selected from the group consisting of acetophenone and benzophenone.
Claim 48
Dependent Claim
17 words
A device according to claim 36 wherein the article is in the form of a vascular graft.
References Cited (Backward Citations)
US5258041A
Cited
US4960423A
Cited
US4979959A
Cited
US5263992A
Cited
US5294551A
Cited
WO1992017218A1
Cited
US5370681A
Cited
US5563056A
Cited
WO1993021971A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2001-04-27 | 2001-10-27 | 2002-04-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2005-04-27 | 2005-10-27 | 2006-04-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2009-04-27 | 2009-10-27 | 2010-04-28 | $7700.00 | Window Closed / Lapsed |